Shaanxi Kanghui Pharmaceutical Co., Ltd.

Shanghai Stock Exchange 603139.SS

Shaanxi Kanghui Pharmaceutical Co., Ltd. Revenue Per Share for the year ending December 31, 2023: USD 0.94

Shaanxi Kanghui Pharmaceutical Co., Ltd. Revenue Per Share is USD 0.94 for the year ending December 31, 2023, a 32.11% change year over year. Revenue per share indicates revenue generated per share; higher ratios suggest stronger performance and value.

Shaanxi Kanghui Pharmaceutical Co., Ltd. Revenue Per Share for the year ending December 31, 2022 was USD 0.71, a 2.22% change year over year.
Shaanxi Kanghui Pharmaceutical Co., Ltd. Revenue Per Share for the year ending December 31, 2021 was USD 0.70, a 9.85% change year over year.
Shaanxi Kanghui Pharmaceutical Co., Ltd. Revenue Per Share for the year ending December 31, 2020 was USD 0.64, a 2.39% change year over year.
Shaanxi Kanghui Pharmaceutical Co., Ltd. Revenue Per Share for the year ending December 31, 2019 was USD 0.62, a 12.82% change year over year.

Key data

Date	Revenue Per Share	Dividend Per Share	Free Cash Flow Per Share	Return on Assets (ROA)

Shanghai Stock Exchange: 603139.SS

Shaanxi Kanghui Pharmaceutical Co., Ltd.

CEO	Mr. Yanling Wang
IPO Date	April 21, 2017
Location	China
Headquarters	High-tech Industrial Development Zone
Employees	952
Sector	Health Care
Industries Pharmaceuticals

Description

Shaanxi Kanghui Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in China. It offers gynecological, orthopedic, dermatology, diabetes, respiratory system, urinary system, cardiovascular and cerebrovascular, gastrointestinal, hepatobiliary, and other drugs in the form of tablets, capsules, granules, mixtures, teas, plasters, ointments, liniments, lotions, and tinctures. The company is based in Xianyang, China.

Key trends

Past 5 years